Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
80%(4 trials)

Phase Distribution

Ph phase_1
1
14%
Ph phase_3
3
43%
Ph phase_2
3
43%

Phase Distribution

1

Early Stage

3

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
3(42.9%)
Phase 3Large-scale testing
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(5)

Detailed Status

Completed5
Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 23 (42.9%)
Phase 33 (42.9%)

Trials by Status

completed571%
not_yet_recruiting229%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingphase_3

A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

NCT07184645
not_yet_recruitingphase_3

A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis

NCT07173478
completedphase_3

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

NCT05372653
completedphase_2

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

NCT02068352
completedphase_2

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

NCT02914548
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07184645Phase 3

A Phase 3 Trial of OPA-15406 Foam in Children and Infants With Atopic Dermatitis

Not Yet Recruiting
NCT07173478Phase 3

A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis

Not Yet Recruiting
NCT05372653Phase 3

A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis

Completed
NCT02068352Phase 2

A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis

Completed
NCT02914548Phase 2

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

Completed
NCT03018691Phase 2

Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

Completed
NCT01702181Phase 1

A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7